MeiraGTx Holdings (MGTX) Deferred Taxes (2017 - 2018)
MeiraGTx Holdings (MGTX) posted Deferred Taxes of -$12.4 million for Q4 2018, down 92970.79% on a QoQ basis from -$13365.0 in Q3 2018, and down 430.95% year-over-year from $3.8 million in Q4 2017.
MeiraGTx Holdings (MGTX) Deferred Taxes (2017 - 2018) Analysis & Trends
MeiraGTx Holdings' Deferred Taxes history runs 2 years deep, the most recent figure standing at -$12.4 million for Q4 2018.
- Quarterly Deferred Taxes fell 430.95% year-over-year to -$12.4 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$12.5 million (changed N/A YoY) and the FY2019 annual result came in at -$9.8 million, up 21.96% from the prior year.
- Deferred Taxes was -$12.4 million for Q4 2018 at MeiraGTx Holdings, down from -$13365.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $3.8 million in Q4 2017 and bottomed at -$12.4 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -12.44 Mn |
| Sep 30, 2018 | -13,365.00 |
| Jun 30, 2018 | -16,335.00 |
| Mar 31, 2018 | -25,760.00 |
| Dec 31, 2017 | 3.76 Mn |
| Sep 30, 2017 | 399,776.00 |